PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2026Cureus0 citationsOpen Access

Hypovitaminosis D and Insulin Resistance in Type 1 Diabetes Mellitus: A Systematic Review of Clinical and Mechanistic Evidence

YAYusuf AhmedAAAli Hadi M AlhajriSOSami M Osman

Key Points

  • To assess the relationship between hypovitaminosis D and insulin resistance in people with type 1 diabetes mellitus.
  • Conducted a systematic review using PRISMA guidelines.
  • Searched multiple databases for relevant studies on vitamin D and insulin resistance in T1DM.
  • Included studies that evaluated vitamin D status and insulin resistance measures.
  • Utilized Cochrane Risk of Bias 2 tool and Newcastle-Ottawa Scale for bias evaluation.
  • Performed narrative synthesis due to study heterogeneity.
  • Hypovitaminosis D prevalence in T1DM ranged from 47 to 79%.
  • Six studies found significant associations between low vitamin D levels and insulin resistance markers.
  • Positive correlation between vitamin D and estimated glucose disposal rate (eGDR) was noted.
  • Mechanistic studies indicated sufficient vitamin D preserves β-cell function.
  • Supplementation trials yielded conflicting outcomes, with longitudinal studies showing no significant long-term association.

Abstract

Type 1 diabetes mellitus (T1DM) involves autoimmune β-cell destruction, but insulin resistance may also influence disease outcomes. Vitamin D modulates insulin sensitivity and immune function, and hypovitaminosis D is common in T1DM. This systematic review evaluates clinical and mechanistic evidence on the association between hypovitaminosis D and insulin resistance in T1DM. A Preferred Reporting Items for Systematic Reviews and Meta‑Analyses (PRISMA) framework was applied for a systematic search of PubMed®, BMJ Journals, Scopus®, IEEE Xplore®, and Web of Science™, including articles published until 7 March 2026. Studies assessing vitamin D status and insulin resistance measures in T1DM populations were included. Risk of bias was evaluated using the Cochrane Risk of Bias 2 tool and the Newcastle-Ottawa Scale. Narrative synthesis was performed due to methodological heterogeneity. Eight studies (one controlled trial, two prospective cohorts, and five cross-sectional) were included. Hypovitaminosis D prevalence ranged from 47 to 79%. Six studies reported significant associations between low vitamin D levels and markers of insulin resistance, including a positive correlation with estimated glucose disposal rate (eGDR), as well as associations with higher insulin requirements and greater odds of insulin resistance. Mechanistic studies demonstrated preserved β-cell function with sufficient vitamin D and identified vitamin D receptor (VDR) polymorphisms as effect modifiers. Supplementation trials showed conflicting results, and longitudinal analysis revealed no significant association over time. Risk of bias was low in one study, good in five, and fair in two. Hypovitaminosis D is prevalent in T1DM and associated with insulin resistance in cross-sectional studies, with supportive mechanistic evidence. However, interventional and longitudinal data remain inconsistent. Vitamin D may be a marker of metabolic dysregulation, but its therapeutic role in improving insulin resistance requires further robust investigation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ahmed et al. (2026) studied this question.

synapsesocial.com/papers/69cb6589e6a8c024954b9968https://doi.org/10.7759/cureus.106061
Ask AI
Helpful
Bookmark
Share
View Full Paper